Strata Critical Medical, Inc.
SRTA
$5.43
-$0.06-1.09%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 290.94% | 263.09% | 181.59% | 65.40% | 50.89% |
| Total Depreciation and Amortization | 120.56% | 93.68% | 26.03% | -33.17% | -38.62% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -570.06% | -607.82% | -374.03% | -58.39% | -10.73% |
| Change in Net Operating Assets | -249.34% | -69.88% | 154.96% | -175.94% | 180.12% |
| Cash from Operations | -450.25% | -1,841.80% | -319.94% | 108.97% | 141.19% |
| Capital Expenditure | 47.63% | 55.17% | 27.12% | 46.36% | -924.70% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 405.60% | 348.06% | 445.66% | 180.79% | 12.03% |
| Cash from Investing | 1,532.45% | 6,965.16% | 1,227.94% | 761.04% | -120.38% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 46.83% | 22.93% | 52.50% | -8.53% | 17.76% |
| Repurchase of Common Stock | 43.08% | -75.60% | -765.61% | -614.56% | -9,168.63% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 45.07% | -54.75% | -478.83% | -744.29% | -201,280.00% |
| Foreign Exchange rate Adjustments | -4,750.00% | -138.73% | -2,388.89% | 241.18% | 110.53% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,082.25% | 223.59% | 109.54% | 389.76% | 58.81% |